Picture of Atomo Diagnostics logo

AT1 — Atomo Diagnostics Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-14.8%
3m-46.7%
6m-54.32%
1yr-52.45%
Volume Change (%)
10d/3m-44.8%
Price vs... (%)
52w High-75.57%
50d MA-20.88%
200d MA-56.78%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-20.96%
Return on Equity-19.33%
Operating Margin-79.04%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202230th Jun 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Atomo Diagnostics EPS forecast chart

Profile Summary

Atomo Diagnostics Ltd is an Australia-based medical device company. The Company is engaged in the development and sale of medical devices. Its AtomoRapid is offering rapid diagnostic test (RDT) platform, which provides devices to the global diagnostic market. Its RDT device platforms include Galileo, Pascal, Losev, Newton, Franklin and Elion. It also offers blood-based rapid diagnostic test (RDT) for screening for human immunodeficiency virus (HIV). Its RDT platform includes various features, such as integrated lancelet, blood collection, buffer delivery and digital display. It is also engaged in sales of Atomo branded COVID-19 rapid antibody and antigen tests in Australia.

Directors

Last Annual
June 30th, 2021
Last Interim
December 31st, 2021
Incorporated
April 1st, 2010
Public Since
January 1st, 1970
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
568,597,807
Blurred out image of a map
Address
Level 2, SYDNEY, 2040
Web
http://atomodiagnostics.com/
Phone
Auditors
BDO Audit Pty Ltd

AT1 Share Price Performance

Upcoming Events for AT1

Full Year 2022 Atomo Diagnostics Ltd Earnings Release

Atomo Diagnostics Ltd Annual Shareholders Meeting

Similar to AT1

Picture of 4DMedical logo

4DMedical

au flag iconAustralian Stock Exchange - SEATS

Picture of Adherium logo

Adherium

au flag iconAustralian Stock Exchange - SEATS

Picture of Allegra Orthopaedics logo

Allegra Orthopaedics

au flag iconAustralian Stock Exchange - SEATS

Picture of Analytica logo

Analytica

au flag iconAustralian Stock Exchange - SEATS

Picture of Ansell logo

Ansell

au flag iconAustralian Stock Exchange - SEATS

FAQ

Or unlock with your email

Or unlock with your email